Catherine O’Connor Congratulations 🎉🎊!! Such an honor and privilege to have had the opportunity to mentor such a stellar student. I can’t wait to see your future achievements and advancements.

Eileen M O’Reilly Wungki Park, MD MS Fergus Keane Emily Harrold Mary Helen Larsen MSKCC Center for Pancreatic Cancer Research MSK Department of Medicine Thanks Dr. O’Reilly!! Couldn’t have a better mentor to look up to 🥰

I am also especially thankful to have had the best role models in medicine and science in the world for the past four years, including Eileen M O’Reilly, Wungki Park, MD MS, Dr. TS, Fergus Keane, Emily Harrold, and Mary Helen Larsen. Boston and HMS, I will see you in August! 🩺❤️ (2/2)

#OpenAccess in Nature Medicine
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
nature.com/articles/s4159…
Fantastic study that uses tens of thousands of cytology cases for training & test sets for assessing CUP patients.

Congratulations 🎉🎊!! Such an honor and privilege to have had the opportunity to mentor this stellar student Catherine O’Connor with Eileen M O’Reilly I can’t wait to see her future achievements and advancements.

Congrats American University of Beirut on impeccable audit of Memorial Sloan Kettering Cancer Center American University of Beirut Medical Center joint tissue bank. Amazing joint effort of Memorial Sloan Kettering Cancer Center Eileen M O’Reilly #IRB Ali Abu-Alfa Fuad Ziyadeh, MD AUB IRB Mark Robson and many other colleagues since 2013. Thanks Ayman Tawil and Miriam Kanso!

Ghassan Abou-Alfa American University of Beirut Memorial Sloan Kettering Cancer Center American University of Beirut Medical Center Eileen M O’Reilly Ali Abu-Alfa AUB IRB Mark Robson First publication, as fruit of this successful collaboration between Faculty of Medicine and Memorial Sloan Kettering Cancer Center, in JCO Global Oncol in 2023

Ghassan Abou-Alfa American University of Beirut Memorial Sloan Kettering Cancer Center American University of Beirut Medical Center Eileen M O’Reilly Ali Abu-Alfa AUB IRB Mark Robson First publication, as fruit of this successful collaboration between Faculty of Medicine and Memorial Sloan Kettering Cancer Center, in JCO Global Oncol in 2023

Congratulations to our PanCAN Chief Science Officer, Lynn Matrisian, PhD, MBA for being elected as an AAAS Fellow for Biological Sciences! #AAASFellows

With this esteemed honor, she joins the ranks of some of the most prominent scientists in history for her distinguished

⚡Our April issue is live! Featuring studies on #cancer #vaccines & #neoadjuvant therapy, clinical #AI , an #AlzheimersDisease blood test, telehealth #abortion , #ParkinsonsDisease , #T2D , and much more including news, reviews & opinion.
nature.com/nm/volumes/30/…

Thank you for the shout-out Anirban! Always so kind 🤗

Eloise Lloyd Joaquín Araos Henríquez and I had such fun writing this. Thanks much to DMM Journal for the invitation. It was great to have the opportunity to write down some of our “thoughts”😉about #PancreaticCancerResearch .

Huge congratulations Lynn!!!! So very well deserved!!!

The Revolution has begun!@MDAndersonNews

The liver can be a path towards establishing immune tolerance for autoimmune diseases. But it also promotes immune evasion of cancer. A mechanism for this is identified here and could prove useful for directing therapy
nature.com/articles/s4159…
Nature Immunology Beatty Lab Penn Medicine

Incredible seminar by Dr. Heather Christofk Christofk Lab for our UC San Francisco BMS seminar series showcasing the critical metabolic changes underlying hereditary tumor syndromes, diabetes and development 🤯

Really enjoyed my first Cholangiocarcinoma Foundation Meeting. Wonderful meeting for learning and collaboration. Cholangiocarcinoma Foundation

Glad to finally see this (it almost didn't happen even with a 9%ile. Don't ask.)! And it's a big boi, $$$-wise!

Not many years ago we had no treatments vs KRAS driver mutations for cancer. Considered undruggable. Now look!
nature.com/articles/s4159…
Nature Medicine Eileen M O’Reilly Memorial Sloan Kettering Cancer Center

New REVIEW out on Nature Medicine by Anupriya Singhal, Bob T. Li & Eileen M O’Reilly 🇺🇸

Targeting KRAS🧬 in #CancerResearch
Link: nature.com/articles/s4159…

RAS family variants, primarily KRAS, are prevalent hotspot mutations in human cancers with historically limited treatment